Clinical Evaluation Report (CER) Consulting Services

Develop comprehensive, evidence-based Clinical Evaluation Reports (CERs) that demonstrate the safety, clinical performance, and benefit-risk profile of your medical devices. Our regulatory experts help you achieve EU MDR compliance and accelerate market access with confidence.

EU MDR CER Writing & Clinical Evaluation

Demonstrate Clinical Safety, Performance & EU MDR Compliance with Confidence

Prepare scientifically robust, MDR-compliant Clinical Evaluation Reports (CERs) aligned with EU MDR 2017/745 Annex XIV, MEDDEV 2.7/1 Rev.4, and the latest MDCG guidance to support CE certification and successful Notified Body reviews.

Whether you are developing a new medical device, transitioning from MDD to MDR, renewing your CE certification, or updating an existing CER, our multidisciplinary quality, regulatory, and clinical experts deliver evidence-based clinical evaluations that accelerate market access, ensure regulatory compliance, and support a seamless transition from legacy MDD documentation to full EU MDR compliance.

Our Clinical Evaluation Report (CER) services are delivered by a multidisciplinary team of quality, regulatory, and clinical experts with extensive experience supporting medical device manufacturers throughout the product lifecycle. From CER strategy and Clinical Evaluation Plan (CEP) development to literature reviews, clinical data appraisal, CER preparation, remediation, and updates, we help develop scientifically robust, submission-ready documentation aligned with EU MDR 2017/745 and the latest MDCG guidance.

Our Clinical Evaluation Services

01

Clinical Evaluation Strategy & CER Planning

Establish a tailored clinical evaluation strategy based on your device classification, intended purpose, clinical claims, and available evidence to support a compliant and efficient regulatory pathway.

02

Clinical Evaluation Plan (CEP)

Develop a structured Clinical Evaluation Plan (CEP) that defines the methodology and framework for the clinical evaluation process.

Includes:
  • Clinical Evaluation scope
  • Clinical evaluation methodology
  • Clinical development strategy
  • Clinical questions to demonstrate safety and performance
03

Literature Search & Review

Conduct systematic and comprehensive literature searches using recognized scientific databases to identify relevant clinical evidence supporting your device.

Databases:
  • PubMed
  • Embase
  • Google Scholar
  • Cochrane Library
  • ScienceDirect
04

State-of-the-Art (SOTA) Assessment

Prepare a comprehensive State-of-the-Art (SOTA) assessment to demonstrate current clinical knowledge, available treatment options, and the device's position within existing medical practice.

Includes:
  • Current clinical practice
  • Alternative treatments
  • Clinical guidelines
  • Applicable standards
  • Benchmark devices
05

Post-Market Surveillance (PMS)

Integrate post-market surveillance data into the clinical evaluation to maintain ongoing compliance and support CER updates.

Updates:
  • Incorporation of Internal Complaint data
  • Incorporation of Field Safety Corrective Action (FSCA), CAPA and Recall
  • Vigilance updates
06

Clinical Data Appraisal

Critically evaluate all available clinical evidence to assess its relevance, quality, and adequacy for demonstrating safety and performance.

Includes:
  • Clinical investigations
  • Published literature
  • Equivalent device data
  • Post-Market Surveillance (PMS)
  • Complaint and vigilance data
  • PMCF data
07

Benefit-Risk Assessment

Assess whether the demonstrated clinical benefits outweigh the identified residual risks throughout the device lifecycle.

Includes:
  • Clinical benefits
  • Residual risks
  • Risk control measures
  • Benefit-risk acceptability
  • Alignment with ISO 14971 Risk Management File
  • Clinical benefit justification
  • Residual risk evaluation
08

Clinical Evaluation Report (CER)

Prepare a scientifically robust, submission-ready Clinical Evaluation Report that complies with EU MDR 2017/745, MEDDEV 2.7/1 Rev.4, and applicable MDCG guidance which supports successful Notified Body review.

Compliant With:
  • EU MDR 2017/745
  • Annex XIV
  • MEDDEV 2.7/1 Rev.4
  • MDCG Guidance Documents
09

CER Gap Analysis & Assessment

Review existing Clinical Evaluation Reports against:
  • EU MDR Annex XIV
  • MEDDEV 2.7/1 Rev.4
  • MDCG Guidance and Notified Body expectations
Deliverables:
  • Gap Assessment Report
  • Compliance Matrix
  • Remediation Plan

EU MDR Medical Device Risk Classification We Support

Comprehensive regulatory and clinical evaluation support across all medical device classes under EU MDR 2017/745, helping manufacturers achieve CE certification with confidence.

Class I

Low Risk

Examples

Manual wheelchairs, examination lights, non-invasive medical devices

Class Is (Sterile)

Low Risk

Examples

Sterile surgical drapes, sterile dressings, sterile examination gloves

Class Im (Measuring)

Low Risk

Examples

Clinical thermometers, blood pressure monitors, measuring syringes

Class Ir (Reusable)

Low Risk

Examples

Surgical forceps, scissors, clamps, retractors

Class IIa

Medium Risk

Examples

Infusion pumps, suction devices, hearing aids, dental equipment, diagnostic ultrasound systems

Class IIb

Medium to High Risk

Examples

Ventilators, anesthesia workstations, orthopedic implants, dialysis equipment, infusion pumps

Class III

High Risk

Examples

Heart valves, pacemakers, coronary stents, breast implants, implantable neurostimulators

Industries We Serve

Cardiovascular & Vascular

Orthopedics

Dental

General Surgery

Gastroenterology

Ophthalmology

Neurology

Respiratory

Diagnostics

Digital Health

AI-Enabled Devices

Robotic Devices

ENT

Wound Care

Our CER Deliverables

Clinical Evaluation Plan
Literature Search Protocol
Literature Review Report
State-of-the-Art Report
Clinical Data Appraisal
Clinical Benefit-Risk Assessment Report
Clinical Evaluation Report
CER Update Report
CER Gap Assessment Report
Notified Body Response Support

CER Update Services & Maintenance

Keep your Clinical Evaluation Report current and compliant throughout the product lifecycle by incorporating new clinical evidence, post-market data, and regulatory changes.

Our support includes:

Annual CER updates & Periodic reviews

Design and product changes

Integration of new clinical evidence

EU MDR renewal support

PMS & PMCF data incorporation

Notified Body observation support

Vigilance updates

PMS, Field Safety Corrective Action (FSCA) integration

Legacy Device CER remediation and modernization for MDR compliance

Clinical Evaluation Report

Our Clinical Evaluation Process

Step 01

Project Kick-off & planning

Initiate the project by understanding your device, defining the scope, and reviewing the available documentation.

Includes:
  • Scope definition
  • Device understanding
  • Documentation review
Step 02

Gap Assessment

Assess existing documentation and available clinical evidence to identify gaps against EU MDR requirements.

Review Includes:
  • Clinical data
  • Risk Management File
  • Post-Market Surveillance (PMS)
  • Post-Market Clinical Follow-up (PMCF)
  • Instructions for Use (IFU)
  • Technical Documentation
Step 03

Literature Search

Conduct a systematic literature search using a predefined methodology to identify relevant clinical evidence from recognized scientific sources.

Step 04

Clinical Data Evaluation

Critically appraise and analyze the collected clinical evidence to determine its quality, relevance, and sufficiency.

Includes:
  • Clinical data appraisal
  • Evidence weighting
  • Clinical relevance assessment
Step 05

CER Preparation

Prepare a scientifically justified and MDR-compliant Clinical Evaluation Report based on the evaluated clinical evidence.

Step 06

CER Quality Review

Perform an independent technical and regulatory review to ensure the CER is accurate, complete, and submission-ready.

Step 07

Final Delivery

Deliver a finalized Clinical Evaluation Report with all supporting documentation, ready for Notified Body submission and regulatory review.

Step 01 / 07

Regulatory Expertise Across Device Categories

Our Clinical Evaluation Report (CER) services support a broad range of medical technologies across multiple device categories, ensuring compliance with EU MDR 2017/745 and global regulatory requirements.

High-tech medical device interior

Active Medical Devices

Clinical evaluation support for electrically powered and active medical devices.

Examples:
Patient Monitoring DevicesElectrosurgical Equipment Surgical Navigation SystemsInfusion SystemsDiagnostic & Imaging Devices VentilatorsAnesthesia Systems
High-tech medical device interior

Non-Active Medical Devices

Clinical evaluation for implantable, reusable, and non-powered medical devices across various therapeutic areas.

Examples:
Orthopedic ImplantsDental Devices Surgical InstrumentsWound Care Products Disposable Medical Devices Catheters & Cannulas
High-tech medical device interior

Software as a Medical Device (SaMD)

Regulatory and clinical evaluation support for software-driven medical technologies and digital health solutions.

Examples:
AI/ML Medical Software Diagnostic Software Mobile Medical Applications Clinical Decision Support Systems (CDSS)Remote Patient Monitoring SolutionsDigital Therapeutics

Global Regulatory Expertise

Supporting Global Regulatory Compliance Across Markets

EU MDR

UKCA

FDA

Health Canada

TGA

PMDA

CDSCO

ASEAN

GCC

Standards & Guidelines We Follow

Supporting Global Regulatory Compliance Across Markets

EU MDR 2017/745

Annex XIV, Annex II & III

MEDDEV 2.7/1 Rev.4

Clinical Evaluation Guidance

MDCG Guidelines

Clinical Evaluation Guidance

ISO 14971

Risk Management

ISO 14155

Clinical Investigation

ISO 13485

Quality Management System

Why Choose Us?

Our dedicated Clinical Evaluation Consultants bring deep expertise across all EU MDR device classes, combining regulatory knowledge, clinical evidence evaluation, and industry best practices to develop compliant, audit-ready CERs that support successful market access and Notified Body expectations.

Regulatory & Clinical Expertise

Experienced multidisciplinary team specializing in medical devices, IVDs, and digital health technologies.

MDR-Focused Approach

Reports prepared in accordance with current EU MDR requirements and recognized guidance documents.

Scientific Excellence

Evidence-based clinical evaluations supported by comprehensive literature searches and critical appraisal.

End-to-End Support

From Clinical Evaluation Plan (CEP) through Clinical Evaluation Report (CER), and Notified Body response support.

Global Regulatory Experience

Supporting manufacturers targeting European and international markets across multiple device technologies.

Notified Body Response Support

Expert assistance in addressing Notified Body observations and regulatory queries.

Independent Quality Review

Every deliverable undergoes an independent technical and regulatory quality review.

Clinical Evaluation Strategy Consulting

Tailored clinical evidence strategies to support efficient regulatory pathways and market access.

Systematic Literature Search & Review Specialists

Comprehensive literature searches using internationally recognized scientific databases and methodologies

Regulatory Experts across EU MDR, FDA, UKCA, TGA, Health Canada, PMDA, CDSCO, and GCC Requirements

Supporting global regulatory submissions across EU, FDA, UKCA, TGA, Health Canada, PMDA, CDSCO, ASEAN, and GCC markets.

Case Studies

Case Study 1
Case Open

Product

Clinical Evaluation Report (CER) for a Syringe & Large Volume Infusion Pump for a Global Medical Device Leader in Infusion Systems and Drug Delivery Technologies

SARACA's Role

  • Developed the Clinical Evaluation Plan (CEP) defining clinical questions, evaluation methodology, and literature search strategy in accordance with EU MDR 2017/745 and MEDDEV 2.7.1 Rev.4.
  • Conducted systematic literature search, screening, and critical appraisal to identify relevant clinical evidence for infusion pumps and equivalent devices
  • Performed vigilance and post-market data analysis (e.g., MAUDE, recalls) to assess safety signals and real-world device performance.
  • Prepared the MDR-compliant Clinical Evaluation Report (CER) including clinical data synthesis and benefitโ€“risk evaluation to support regulatory submission.

Value Proposition

Delivered MDR-compliant clinical evidence demonstrating the safety, performance, and benefit-risk profile of the infusion pump to support regulatory approval and market access.

Case Study 2
Case Open

Project

Clinical Evaluation, Risk Management, and Biological Evaluation Plan and Report for Class IIb and Class III In-vitro fertilization medical devices

SARACA's Role

  • Developed Clinical Evaluation, Risk Management and Biological Evaluation plan & report per EU MDR, ISO 14971:2019 and ISO 10993.
  • Identified and Remediated IFUs which incorporates medicinal substance, human tissues/plasma and animal tissue etc
  • Identified and updated the respective FMEAs and Hazards Analysis documents for the Hazards related to medicinal substance, human tissues/plasma and animal tissue etc

Key Challenges

  • Identify the exclusion criteria for clean and transparent review
  • 1000+ articles reviewed and found 50+ articles relevant for both S&P and SOA, summarize them in short span of time to meet the timelines of 4 to 6 weeks for technical file completion.

Value Proposition

  • Collaborated with customer's cross functional team for accomplishing timely submission of EU MDR Technical file.
Case Study 3
Case Open

Problem Statement:

Development of Tech File compliant to EU MDR

Value Proposition by Saraca:

Development of Tech File compliant to EU MDR

Device Expertise:

35+ Devices Across All Risk Classes (I, IIa, IIb, III)

Full ownership:

  • End to end development
  • Post audit support
  • Annual renew

Orthopedic and Spinal implants:

  • Plates
  • Nails
  • Spinal Cages
  • Screws
  • Instruments
  • Wedges

Application Areas:

  • Knee
  • Hip
  • Upper & Lower Extremities
  • Spine
  • Cranial
  • Maxillofacial
  • Shoulder

Customer

US based medical devices company having global footprint

About Us

SARACA is a rapidly growing product engineering services company with deep expertise in digital, artificial intelligence, and emerging new technologies. Founded in 2014, SARACA is powered by Gen Z and Millennials with greater focus on agility, customer centricity, faster technology adoption, and adherence to cultural sensitivity. Our digital natives perform their actions with speed and ensure that we exceed customer expectation every single time. SARACA adopted vertically integrated approach to build depth in the industries we operate in. Over the years we have built strong expertise in aerospace, defense, space, automotive, medical devices, Industrial, Farm Equipment, rail transportation, technology, semiconductor, and many other industries.

Contact Us

Saraca Logo

ยฉ2026 Saraca Solutions Private Limited